Massive Analysis Finds Only 3 Supplements Show ‘Unrealistically Large’ Effects on Depression
Extraordinary claims require extraordinary evidence.
“`html
A comprehensive review of depression treatment research has raised questions about the reliability of studies examining dietary supplements and plant-based remedies. Scientists conducting a network meta-analysis examined 163 randomized controlled trials involving nearly 16,000 adults with major depressive disorder to evaluate the effectiveness of 137 different nutrient and plant-based treatments compared to placebos or standard antidepressants.
The analysis revealed that while several supplements appeared beneficial, only three showed promise worthy of further investigation: EPA, an omega-3 fatty acid; vitamin D3; and a specific St. John’s wort extract called ZE117. However, researchers discovered a troubling pattern—studies reporting the largest benefits for these supplements tended to have lower quality standards. The effect sizes observed were unrealistically large compared to what rigorous clinical trials typically demonstrate, suggesting potential bias in study design or execution.
Additional compounds including saffron and curcumin demonstrated possible benefits for anxiety and depression symptoms, though evidence remained limited. The researchers emphasized that more rigorous, large-scale studies are necessary before drawing firm conclusions about supplement effectiveness. They also noted significant gaps in safety data, particularly regarding long-term use and suicide risk, across most existing trials.
The findings, published in Molecular Psychiatry, underscore a substantial gap between preliminary promise and proven efficacy. While certain supplements warrant further investigation, the current evidence base remains insufficient to recommend them as reliable depression treatments.
“`
Originally reported by Sciencealert →
About the Author
